How Mavatar aims to accelerate the path from research to patient
Mavatar is a Swedish company specialising in AI- and data-driven precision medicine.
“Our goal is to make medical research and treatment more personalised, faster, and more accurate for all diseases,” says Johan Juhlin.
“Our goal is to make medical research and treatment more personalised, faster, and more accurate for all diseases,” says Johan Juhlin.
Johan Juhlin, CEO and cofounder, Mavatar
The company is built on 20 years of research in precision medicine, and scientists with backgrounds in molecular biology, bioinformatics, and AI develop the products.
“The core of our technology is DINA (Deep Integrated Network Analysis) – a proprietary data platform that integrates and analyzes millions of research studies from around the world to understand how diseases arise, progress, and respond to treatment,” says CEO Johan Juhlin.
Read the full interview (in Swedish) at this link >>
Current news from Stockholm Science City
